Calcitriol

CHEMBL846 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
416.6 g/mol
LogP
5.1
Phase
4

The active hormonal form of vitamin D that regulates calcium and phosphate absorption in the intestines and controls bone metabolism. It is used to treat hypocalcemia and metabolic bone disease in patients with chronic kidney disease or hypoparathyroidism, who cannot adequately convert vitamin D to its active form. Careful dosing is required to avoid dangerously high calcium levels.

Khối lượng phân tử

416,6000 g/mol

LogP

5,10

TPSA

60,70 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Cơ chế tác dụng

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O

InChI

InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1

Molecular Formula

C27H44O3

HBD / HBA

3 / 3

Liên kết có thể quay

6

Nguyên tử nặng

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

The active hormonal form of vitamin D that regulates calcium and phosphate absorption in the intestines and controls bone metabolism. It is used to treat hypocalcemia and metabolic bone disease in patients with chronic kidney disease or hypoparathyroidism, who cannot adequately convert vitamin D to its active form. Careful dosing is required to avoid dangerously high calcium levels.

Serves as an essential micronutrient cofactor in various enzymatic reactions and metabolic processes. Supplementation corrects deficiency states and supports normal physiological function.

Yes, Calcitriol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL846. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5280453. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.